Comparative Pharmacology
Head-to-head clinical analysis: MIDOL versus MIDOL LIQUID GELS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MIDOL versus MIDOL LIQUID GELS.
MIDOL vs MIDOL LIQUID GELS
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Midol is a combination product containing acetaminophen (analgesic/antipyretic via COX inhibition in CNS), caffeine (adenosine receptor antagonist), and pyrilamine (H1 antihistamine). The primary mechanism for dysmenorrhea is prostaglandin synthesis inhibition by acetaminophen.
Acetaminophen inhibits cyclooxygenase (COX) enzymes in the CNS, reducing prostaglandin synthesis, and elevates pain threshold. Caffeine is a CNS stimulant and adenosine receptor antagonist that enhances analgesic effect. Pyrilamine maleate is an H1-antihistamine with sedative properties. The combination provides analgesic, antipyretic, and antihistaminic effects.
Acetaminophen 500 mg, PAM Bromide 15 mg, Pyrilamine Maleate 15 mg: 2 tablets orally every 4-6 hours as needed for dysmenorrhea; maximum 10 tablets per day.
2 capsules orally every 6 hours as needed. Maximum 8 capsules in 24 hours.
None Documented
None Documented
Acetaminophen: 2-3 hours in adults; prolonged to 4-6 hours in neonates or hepatic impairment. Caffeine: 3-6 hours; prolonged in pregnancy or liver disease.
Acetaminophen: 2-3 hours (therapeutic doses); prolonged in overdose (>12 hours) due to saturable metabolism. Caffeine: 3-5 hours (adults).
Renal: >90% as acetaminophen glucuronide and sulfate conjugates; unchanged drug <5%. Biliary/fecal: <5%.
Renal elimination: 85-90% as acetaminophen glucuronide and sulfate conjugates; 5-10% unchanged. Biliary/fecal: minimal (<5%).
Category C
Category C
Analgesic Combination
Analgesic Combination